Lehmann F G, Wegener T
J Toxicol Environ Health. 1979 Mar-May;5(2-3):281-99. doi: 10.1080/15287397909529750.
The incidence of primary liver cell carcinoma was investigated in a prospective study over 6 yr and 5 mo in 403 clinically unselected patients derived from a homogeneous population by means of serial determination of alpha 1-fetoprotein (AFP) by radioimmunoassay. The diagnosis of liver cirrhosis was proved in 90% by laparoscopy and/or histology and/or autopsy. The incidence of primary liver cell carcinoma in liver cirrhosis in the clinically studied patients was 4.47%, significantly lower than in the autopsy material (11.03%; p less than or equal to 0.025). In the follow-up study, all patients with increasing AFP concentrations exhibited a primary liver cell carcinoma. A transitory rise of AFP (higher than 50 ng/ml) was observed in 15.1% of patients with liver cirrhosis without primary liver cell cancer. In contrast to the results of animal experiments, this transitory rise of AFP was not followed by malignant transformation of the cirrhotic tissue. Posthepatitic liver cirrhosis was observed in 21.57%, postalcoholic liver cirrhosis in 42.93%, and cryptogenic liver cirrhosis in 27.30%. Liver cirrhosis of other etiology occurred in 8.19%. The incidences of primary liver cell cancer in these 4 groups were 4.94, 4.62, 5.45, and 0%, respectively. These differences are not statistically significant, although in absolute figures postalcoholic liver cirrhosis is the main cause of primary liver cell carcinoma in this sample from West Germany. HBs antigen-positive liver cirrhosis was more often associated with primary liver cell cancer than HBs antigen-negative liver cirrhosis (6.58 versus 3.96%); this difference also is not statistically significant. Observations of larger groups of patients may show a higher risk of developing primary liver cell carcinoma in those with a combination of alcohol abuse and HBs antigenemia and/or acute hepatitis in the history. Patients without these 2 risk factors had an incidence of primary liver cell carcinoma of 2.61%; those with 1 risk factor, 5.77%; and those with both risk factors, 10.71%.
在一项前瞻性研究中,对来自同质性人群的403例未经临床筛选的患者进行了长达6年零5个月的观察,通过放射免疫分析法连续测定甲胎蛋白(AFP),以研究原发性肝细胞癌的发病率。经腹腔镜检查和/或组织学检查和/或尸检证实,90%的患者患有肝硬化。在临床研究的患者中,肝硬化患者原发性肝细胞癌的发病率为4.47%,显著低于尸检材料中的发病率(11.03%;p≤0.025)。在随访研究中,所有AFP浓度升高的患者均表现为原发性肝细胞癌。在无原发性肝细胞癌的肝硬化患者中,15.1%观察到AFP短暂升高(高于50 ng/ml)。与动物实验结果相反,肝硬化组织并未因AFP的这种短暂升高而发生恶性转化。观察到21.57%的患者为肝炎后肝硬化,42.93%为酒精性肝硬化,27.30%为隐源性肝硬化。其他病因的肝硬化发生率为8.19%。这4组患者原发性肝细胞癌的发病率分别为4.94%、4.62%、5.45%和0%。尽管从绝对数字来看,酒精性肝硬化是来自西德的这个样本中原发性肝细胞癌的主要病因,但这些差异无统计学意义。HBs抗原阳性的肝硬化比HBs抗原阴性的肝硬化更常与原发性肝细胞癌相关(6.58%对3.96%);这种差异也无统计学意义。对更多患者群体的观察可能会显示,有酗酒史且伴有HBs抗原血症和/或急性肝炎的患者发生原发性肝细胞癌的风险更高。没有这两种危险因素的患者原发性肝细胞癌的发病率为2.61%;有1种危险因素的患者为5.77%;有两种危险因素的患者为10.71%。